2022

1. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6

   Epilepsia, Vol. 63, Núm. 5, pp. 1189-1199